Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine in Stable Coronary Artery Disease
NCT04434365Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of berberine in coronary artery disease (CAD), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
berberine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04434365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04434365.